{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:34:09Z","timestamp":1790422449545,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07589-7","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T17:14:57Z","timestamp":1766164497000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["ZDHHC9 and spermine metabolism: a palmitoylation-driven pathway to prostate carcinogenesis"],"prefix":"10.1186","volume":"24","author":[{"given":"Chunli","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaofa","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengqiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junshuo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangkang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"7589_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"7589_CR2","doi-asserted-by":"crossref","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368.","DOI":"10.1126\/science.aaw5473"},{"key":"7589_CR3","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41568-018-0050-3","volume":"18","author":"RA Casero Jr","year":"2018","unstructured":"Casero RA Jr, Murray Stewart T, Pegg AE. Polyamine metabolism and cancer: treatments, challenges and opportunities. Nat Rev Cancer. 2018;18:681\u201395.","journal-title":"Nat Rev Cancer"},{"key":"7589_CR4","doi-asserted-by":"publisher","first-page":"C341","DOI":"10.1152\/ajpcell.00074.2024","volume":"327","author":"RS Schibalski","year":"2024","unstructured":"Schibalski RS, Shulha AS, Tsao BP, Palygin O, Ilatovskaya DV. The role of polyamine metabolism in cellular function and physiology. Am J Physiol Cell Physiol. 2024;327:C341\u2013c56.","journal-title":"Am J Physiol Cell Physiol"},{"key":"7589_CR5","doi-asserted-by":"publisher","first-page":"e0162217","DOI":"10.1371\/journal.pone.0162217","volume":"11","author":"TH Tsoi","year":"2016","unstructured":"Tsoi TH, Chan CF, Chan WL, Chiu KF, Wong WT, Ng CF, et al. Urinary polyamines: a pilot study on their roles as prostate cancer detection biomarkers. PLoS One. 2016;11:e0162217.","journal-title":"PLoS One"},{"key":"7589_CR6","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/nm1095-1040","volume":"1","author":"RC Smith","year":"1995","unstructured":"Smith RC, Litwin MS, Lu Y, Zetter BR. Identification of an endogenous inhibitor of prostatic carcinoma cell growth. Nat Med. 1995;1:1040\u201345.","journal-title":"Nat Med"},{"key":"7589_CR7","doi-asserted-by":"publisher","first-page":"112798","DOI":"10.1016\/j.celrep.2023.112798","volume":"42","author":"X Li","year":"2023","unstructured":"Li X, Li F, Ye F, Guo H, Chen W, Jin J, et al. Spermine is a natural suppressor of AR signaling in castration-resistant prostate cancer. Cell Rep. 2023;42:112798.","journal-title":"Cell Rep"},{"key":"7589_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40170-021-00242-z","volume":"9","author":"MK Andersen","year":"2021","unstructured":"Andersen MK, H\u00f8iem TS, Claes BSR, Balluff B, Martin-Lorenzo M, Richardsen E, et al. Spatial differentiation of metabolism in prostate cancer tissue by MALDI-TOF MSI. Cancer Metab. 2021;9:9.","journal-title":"Cancer Metab"},{"key":"7589_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s11658-025-00776-w","volume":"30","author":"W Li","year":"2025","unstructured":"Li W, Shen J, Zhuang A, Wang R, Li Q, Rabata A, et al. Palmitoylation: an emerging therapeutic target bridging physiology and disease. Cell Mol Biol Lett. 2025;30:98.","journal-title":"Cell Mol Biol Lett"},{"key":"7589_CR10","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1038\/s41467-024-49105-3","volume":"15","author":"H Zhang","year":"2024","unstructured":"Zhang H, Sun Y, Wang Z, Huang X, Tang L, Jiang K, et al. ZDHHC20-mediated S-palmitoylation of YTHDF3 stabilizes MYC mRNA to promote pancreatic cancer progression. Nat Commun. 2024;15:4642.","journal-title":"Nat Commun"},{"key":"7589_CR11","doi-asserted-by":"publisher","first-page":"e3001590","DOI":"10.1371\/journal.pbio.3001590","volume":"20","author":"EL Gorenberg","year":"2022","unstructured":"Gorenberg EL, Massaro Tieze S, Y\u00fccel B, Zhao HR, Chou V, Wirak GS, et al. Identification of substrates of palmitoyl protein thioesterase 1 highlights roles of depalmitoylation in disulfide bond formation and synaptic function. PLoS Biol. 2022;20:e3001590.","journal-title":"PLoS Biol"},{"key":"7589_CR12","doi-asserted-by":"publisher","first-page":"107921","DOI":"10.1016\/j.phrs.2025.107921","volume":"220","author":"S Feng","year":"2025","unstructured":"Feng S, Zhou Y, Guo L, Liang Y, Zhu W. Palmitoylation in cardiometabolic diseases: from molecular mechanisms to clinical implications. Pharmacol Res. 2025;220:107921.","journal-title":"Pharmacol Res"},{"key":"7589_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12943-024-02195-5","volume":"23","author":"Y Mo","year":"2024","unstructured":"Mo Y, Han Y, Chen Y, Fu C, Li Q, Liu Z, et al. ZDHHC20 mediated S-palmitoylation of fatty acid synthase (FASN) promotes hepatocarcinogenesis. Mol Cancer. 2024;23:274.","journal-title":"Mol Cancer"},{"key":"7589_CR14","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s11427-021-2048-2","volume":"65","author":"X Pei","year":"2022","unstructured":"Pei X, Li KY, Shen Y, Li JT, Lei MZ, Fang CY, et al. Palmitoylation of MDH2 by ZDHHC18 activates mitochondrial respiration and accelerates ovarian cancer growth. Sci China Life Sci. 2022;65:2017\u201330.","journal-title":"Sci China Life Sci"},{"key":"7589_CR15","doi-asserted-by":"publisher","first-page":"111194","DOI":"10.1016\/j.celrep.2022.111194","volume":"40","author":"Y Sun","year":"2022","unstructured":"Sun Y, Zhang H, Meng J, Guo F, Ren D, Wu H, et al. S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K\/AKT pathway. Cell Rep. 2022;40:111194.","journal-title":"Cell Rep"},{"key":"7589_CR16","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1038\/s41388-023-02718-2","volume":"42","author":"Z Lin","year":"2023","unstructured":"Lin Z, Agarwal S, Tan S, Shi H, Lu X, Tao Z, et al. Palmitoyl acyltransferase ZDHHC7 inhibits androgen receptor and suppresses prostate cancer. Oncogene. 2023;42:2126\u201338.","journal-title":"Oncogene"},{"key":"7589_CR17","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/path.4327","volume":"232","author":"M Yeste-Velasco","year":"2014","unstructured":"Yeste-Velasco M, Mao X, Grose R, Kudahetti SC, Lin D, Marzec J, et al. Identification of ZDHHC14 as a novel human tumour suppressor gene. J Pathol. 2014;232:566\u201377.","journal-title":"J Pathol"},{"key":"7589_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s11658-022-00378-w","volume":"27","author":"Q Hu","year":"2022","unstructured":"Hu Q, Tian T, Leng Y, Tang Y, Chen S, Lv Y, et al. The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancer. Cell Mol Biol Lett. 2022;27:71.","journal-title":"Cell Mol Biol Lett"},{"key":"7589_CR19","doi-asserted-by":"publisher","first-page":"111477","DOI":"10.1016\/j.cellsig.2024.111477","volume":"124","author":"B Tang","year":"2024","unstructured":"Tang B, Wang K, Ren Q, Zhou J, Xu Y, Liu L, et al. GALNT14-mediated O-glycosylation drives lung adenocarcinoma progression by reducing endogenous reactive oxygen species generation. Cell Signal. 2024;124:111477.","journal-title":"Cell Signal"},{"key":"7589_CR20","doi-asserted-by":"publisher","first-page":"5872","DOI":"10.1038\/s41467-021-26180-4","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Li X, Yang F, Chen C, Liu P, Ren Y, et al. DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis. Nat Commun. 2021;12:5872.","journal-title":"Nat Commun"},{"key":"7589_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12943-022-01517-9","volume":"21","author":"ZD Shi","year":"2022","unstructured":"Shi ZD, Hao L, Han XX, Wu ZX, Pang K, Dong Y, et al. Targeting HNRNPU to overcome cisplatin resistance in bladder cancer. Mol Cancer. 2022;21:37.","journal-title":"Mol Cancer"},{"key":"7589_CR22","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/s41419-022-05376-6","volume":"13","author":"BY Han","year":"2022","unstructured":"Han BY, Liu Z, Hu X, Ling H. HNRNPU promotes the progression of triple-negative breast cancer via RNA transcription and alternative splicing mechanisms. Cell Death Dis. 2022;13:940.","journal-title":"Cell Death Dis"},{"key":"7589_CR23","doi-asserted-by":"publisher","first-page":"216486","DOI":"10.1016\/j.canlet.2023.216486","volume":"580","author":"X Wang","year":"2024","unstructured":"Wang X, Xu J, Li Q, Zhang Y, Lin Z, Zhai X, et al. RNA-binding protein hnRNPU regulates multiple myeloma resistance to selinexor. Cancer Lett. 2024;580:216486.","journal-title":"Cancer Lett"},{"key":"7589_CR24","doi-asserted-by":"publisher","first-page":"e2309903","DOI":"10.1002\/advs.202309903","volume":"11","author":"W Tian","year":"2024","unstructured":"Tian W, Zhu L, Luo Y, Tang Y, Tan Q, Zou Y, et al. Autophagy deficiency induced by SAT1 potentiates tumor progression in triple-negative breast cancer. Adv Sci (Weinh). 2024;11:e2309903.","journal-title":"Adv Sci (Weinh)"},{"key":"7589_CR25","doi-asserted-by":"publisher","first-page":"217118","DOI":"10.1016\/j.canlet.2024.217118","volume":"598","author":"W Li","year":"2024","unstructured":"Li W, Liu J, Yu T, Lu F, Miao Q, Meng X, et al. ZDHHC9-mediated Bip\/GRP78 S-palmitoylation inhibits unfolded protein response and promotes bladder cancer progression. Cancer Lett. 2024;598:217118.","journal-title":"Cancer Lett"},{"key":"7589_CR26","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s42003-025-07897-0","volume":"8","author":"H Guo","year":"2025","unstructured":"Guo H, Lin Z, Zhang D, Qin Q, Li Z, Yin Y, et al. ZDHHC9-mediated CD38 palmitoylation stabilizes CD38 expression and promotes pancreatic cancer growth. Commun Biol. 2025;8:477.","journal-title":"Commun Biol"},{"key":"7589_CR27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41422-018-0124-5","volume":"29","author":"Y Yang","year":"2019","unstructured":"Yang Y, Hsu JM, Sun L, Chan LC, Li CW, Hsu JL, et al. Palmitoylation stabilizes PD-L1 to promote breast tumor growth. Cell Res. 2019;29:83\u201386.","journal-title":"Cell Res"},{"key":"7589_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-020-00927-w","volume":"13","author":"H Qin","year":"2020","unstructured":"Qin H, Ni H, Liu Y, Yuan Y, Xi T, Li X, et al. RNA-binding proteins in tumor progression. J Hematol Oncol. 2020;13:90.","journal-title":"J Hematol Oncol"},{"key":"7589_CR29","doi-asserted-by":"publisher","first-page":"6200","DOI":"10.1002\/jcp.30311","volume":"236","author":"A Bitaraf","year":"2021","unstructured":"Bitaraf A, Razmara E, Bakhshinejad B, Yousefi H, Vatanmakanian M, Garshasbi M, et al. The oncogenic and tumor suppressive roles of RNA-binding proteins in human cancers. J Cell Physiol. 2021;236:6200\u201324.","journal-title":"J Cell Physiol"},{"key":"7589_CR30","doi-asserted-by":"publisher","first-page":"e2406318","DOI":"10.1002\/advs.202406318","volume":"11","author":"Y Lin","year":"2024","unstructured":"Lin Y, Lin P, Lu Y, Zheng J, Zheng Y, Huang X, et al. Post-translational Modifications of RNA-Modifying proteins in cellular dynamics and disease progression. Adv Sci (Weinh). 2024;11:e2406318.","journal-title":"Adv Sci (Weinh)"},{"key":"7589_CR31","doi-asserted-by":"crossref","unstructured":"Lovci MT, Bengtson MH, Massirer KB. Post-translational Modifications and RNA-Binding proteins. Adv Exp Med Biol. 2016;907:297\u2013317.","DOI":"10.1007\/978-3-319-29073-7_12"},{"key":"7589_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13046-024-03264-9","volume":"44","author":"G Jin","year":"2025","unstructured":"Jin G, Song Y, Fang S, Yan M, Yang Z, Shao Y, et al. hnRNPU-mediated pathogenic alternative splicing drives gastric cancer progression. J Exp Clin Cancer Res. 2025;44:8.","journal-title":"J Exp Clin Cancer Res"},{"key":"7589_CR33","doi-asserted-by":"publisher","first-page":"e2400152","DOI":"10.1002\/adbi.202400152","volume":"8","author":"EJ Lee","year":"2024","unstructured":"Lee EJ, Charles JF, Sinha I, Neppl RL. Loss of HNRNPU in skeletal muscle increases intramuscular infiltration of Ly6C positive cells, leading to muscle atrophy through activation of NF-\u03baB signaling. Adv Biol. 2024;8:e2400152.","journal-title":"Adv Biol"},{"key":"7589_CR34","doi-asserted-by":"publisher","first-page":"6794","DOI":"10.1038\/s41388-019-0917-0","volume":"38","author":"VS Thakur","year":"2019","unstructured":"Thakur VS, Aguila B, Brett-Morris A, Creighton CJ, Welford SM. Spermidine\/spermine N1-acetyltransferase 1 is a gene-specific transcriptional regulator that drives brain tumor aggressiveness. Oncogene. 2019;38:6794\u2013800.","journal-title":"Oncogene"},{"key":"7589_CR35","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1038\/s41467-025-58525-8","volume":"16","author":"C Zheng","year":"2025","unstructured":"Zheng C, Niu G, Tan H, Huang X, Lu J, Mai Q, et al. A noncanonical role of SAT1 enables anchorage independence and peritoneal metastasis in ovarian cancer. Nat Commun. 2025;16:3174.","journal-title":"Nat Commun"},{"key":"7589_CR36","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12885-022-09313-w","volume":"22","author":"Y Mou","year":"2022","unstructured":"Mou Y, Zhang L, Liu Z, Song X. Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma. BMC Cancer. 2022;22:215.","journal-title":"BMC Cancer"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07589-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07589-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07589-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:30:06Z","timestamp":1769171406000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07589-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7589"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07589-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Shanghai Outdo Biotech Company(No. CP-1907012). All tissue donors provided written informed consent. The Animal Ethics Committee of the Hubei University of Medicine approved the animal experiments(NO0.2025-15).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}